Physician profile
William E Coady
NPI 1386651941
$1,120.81
in general payments reported to CMS, 2019-2025
16 companies · $453 in 2025
The $453 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $19.81 · 2021: $49.42 · 2022: $51.88 · 2023: $203 · 2024: $343 · 2025: $453.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $999.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $484.29 | 2021-2025 | Vraylar, Ubrelvy |
| Novo Nordisk INC | $180.49 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Astellas Pharma US INC | $146.24 | 2023-2025 | Veozah |
| Abbott Laboratories | $71.20 | 2021-2025 | Freestyle Libre 3 |
| Astrazeneca Pharmaceuticals Lp | $44.67 | 2024 | Airsupra |
| Lilly USA, LLC | $28.75 | 2024-2025 | Mounjaro |
| Merck Sharp & Dohme LLC | $21.65 | 2024 | Gardasil 9, Gardasil |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.92 | 2023 | Jardiance |
| Allergan, INC. | $19.81 | 2020 | |
| Azurity Pharmaceuticals, INC. | $18.22 | 2025 | Azmiro |
| Exact Sciences Corporation | $14.76 | 2024 | Cologuard Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.14 | 2024 | Xifaxan |
| Pfizer INC. | $14.04 | 2025 | |
| Amgen INC. | $14.03 | 2024 | Prolia, Evenity |
| Currax Pharmaceuticals LLC | $13.91 | 2025 | Contrave |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $13.69 | 2025 | Arexvy, Bexsero, Shingrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Coady listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.